未登录

N

Nehad M. Ayoub

University of Louisiana System

H指数:28

被引数:2,405

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Programmed Death-Ligand 1 and Receptor Tyrosine Kinases in Breast Cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

HPLC with Fluorescence and Photodiode Array Detection for Quantifying Capmatinib in Biological Samples: Application to In Vivo and In Vitro Studies

IF4.6

2022-12-053

OAAI

Prognostic value and immune characteristics of CYP4B1 in lung squamous cell carcinoma: A bioinformatics analysis

ANNALS OF ONCOLOGY

IF65.4

2022-09-010

OAAI

Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study

IF3.4

2021-11-012

OAAI

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-1843

OAAI

Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels

INVESTIGATIONAL NEW DRUGS

IF2.7

2020-08-2416

PREAI

Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor

PHARMACOLOGICAL RESEARCH

IF10.5

2020-08-0150

OAAI

Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking

使用基于结构的多药效团建模和分子对接发现人乙二醛酶-I酶的纳摩尔抑制剂

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

IF3.1

2019-10-1917

PREAI

Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications

金纳米颗粒与血管生成: 分子机制和生物医学应用

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2019-09-0199

OAAI

Antiangiogenic effect of conditioned media derived from triple negative breast cancer cells in brain microvascular endothelial cells in vitro

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Olive oil-derived (-)-oleocanthal for prevention of breast cancer recurrence

CANCER RESEARCH

IF16.6

2019-07-010

PRE

(-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

IF5

2019-02-1526

OAAI

Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches

IF3.4

2019-01-0178

OAAI

Crizotinib inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

CANCER RESEARCH

IF16.6

2018-07-011

PRE

The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic

Maxi-K (BK) 通道拮抗剂Penitrem A作为一种新型的乳腺癌靶向治疗剂

IF5.4

2018-05-1131

OAAI

The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2017-09-0153

OAAI

Vascularity and vascular maturity in breast cancer: a comparative analysis of the different molecular subtypes

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling

IF5.4

2015-01-0837

OAAI

Identification of synthetic lethality compounds from natural products for cancers

EUROPEAN JOURNAL OF CANCER

IF7.1

2014-11-010

PREAI

Indole diterpene alkaloids as novel inhibitors of the Wnt/β-catenin pathway in breast cancer cells

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2013-12-0151

OAAI